Corey N. Fishman

2019

In 2019, Corey N. Fishman earned a total compensation of $1.4M as President and Chief Executive Officer at Iterum Therapeutics plc, a 21% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$151,841
Option Awards$561,000
Salary$551,138
Stock Awards$123,150
Other$4,902
Total$1,392,031

Fishman received $561K in option awards, accounting for 40% of the total pay in 2019.

Fishman also received $151.8K in non-equity incentive plan, $551.1K in salary, $123.2K in stock awards and $4.9K in other compensation.

Rankings

In 2019, Corey N. Fishman's compensation ranked 7,699th out of 13,971 executives tracked by ExecPay. In other words, Fishman earned more than 44.9% of executives.

ClassificationRankingPercentile
All
7,699
out of 13,971
45th
Division
Manufacturing
3,003
out of 5,701
47th
Major group
Chemicals And Allied Products
1,130
out of 2,200
49th
Industry group
Drugs
964
out of 1,886
49th
Industry
Pharmaceutical Preparations
715
out of 1,398
49th
Source: SEC filing on May 7, 2020.

Fishman's colleagues

We found two more compensation records of executives who worked with Corey N. Fishman at Iterum Therapeutics plc in 2019.

2019

Michael Dunne

Iterum Therapeutics plc

Chief Scientific Officer

2019

Judith Matthews

Iterum Therapeutics plc

Chief Financial Officer

News

You may also like